MULPLETA β VANCOCIN ITALIA, approved 2018-07-31 (NDA210923).
31 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System β they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.